AviadoBio Completes Second Cohort in ASPIRE-FTD Trial for AVB-101
AVB-101 Biomarker Data Readout Expected in 2026 Clinical Milestone Shared at AFTD Annual Caregiver Conference AviadoBio, a pioneering gene therapy company dedicated to developing and...